<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Wellstaq on Medium]]></title>
        <description><![CDATA[Stories by Wellstaq on Medium]]></description>
        <link>https://medium.com/@wellstaq?source=rss-9b39cb2d4f1e------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*kJ9Kgh64U6cSv9E5ugNZXg.png</url>
            <title>Stories by Wellstaq on Medium</title>
            <link>https://medium.com/@wellstaq?source=rss-9b39cb2d4f1e------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Thu, 19 Nov 2026 15:39:24 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@wellstaq/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[The Visit Ends. The Relationship Doesn’t Have To.]]></title>
            <link>https://medium.com/@wellstaq/the-visit-ends-the-relationship-doesnt-have-to-25c6d342ea71?source=rss-9b39cb2d4f1e------2</link>
            <guid isPermaLink="false">https://medium.com/p/25c6d342ea71</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[entrepreneurship]]></category>
            <category><![CDATA[small-business]]></category>
            <dc:creator><![CDATA[Wellstaq]]></dc:creator>
            <pubDate>Thu, 19 Nov 2026 00:00:12 GMT</pubDate>
            <atom:updated>2026-11-19T00:00:12.553Z</atom:updated>
            <content:encoded><![CDATA[<p>Why med spas and wellness centers lose most of their client value between appointments, and what to offer instead</p><p>By Aaron Peden, Co-Founder &amp; CMO at Wellstaq. Disclosure: Wellstaq builds a platform for this, so I have a stake in the topic.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*zJ_IvzupUSmzZw7HOgBqOQ.png" /></figure><p>Ask a med spa or wellness center owner about their clients and you’ll usually hear the same thing: they love us, we just don’t see them often enough.</p><p>That’s not a marketing problem. It’s an offer problem. Between visits, there’s nothing for the client to buy.</p><h3>The gap between appointments</h3><p>A client books, has a great experience, and leaves. The next touchpoint is a reminder email weeks later. In between, their health questions go somewhere else: a search engine, an app, another provider.</p><h3>What a between-visit offer can look like</h3><ul><li><strong>Testing under your brand.</strong> Blood tests collected through Quest Diagnostics, Labcorp or at-home options where supported, sold by your practice.</li><li><strong>Results in your portal.</strong> Clients log into something with your name on it, not a third party’s.</li><li><strong>A membership with substance.</strong> Follow-up, education and access built around the client’s goals.</li><li><strong>Eligible clinical programs.</strong> For example, a GLP-1 weight-management program where independent clinicians evaluate each person and decide what’s appropriate. No prescription is guaranteed; availability and eligibility vary.</li></ul><h3>Keep the lanes clear</h3><p>Your brand owns the experience and the relationship. Licensed clinicians own clinical decisions. Licensed pharmacies dispense. Keeping those responsibilities separate is what makes the model credible.</p><h3>The payoff</h3><p>When the next step lives under your brand, the relationship doesn’t stop at checkout. That’s what turns a great visit into recurring revenue.</p><p><a href="https://wellstaq.com/"><strong>Learn more at Wellstaq.com.</strong></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=25c6d342ea71" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[An Audience Is Not a Business Until It Has Something to Buy Next]]></title>
            <link>https://medium.com/@wellstaq/an-audience-is-not-a-business-until-it-has-something-to-buy-next-86a87cd6a696?source=rss-9b39cb2d4f1e------2</link>
            <guid isPermaLink="false">https://medium.com/p/86a87cd6a696</guid>
            <category><![CDATA[entrepreneurship]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[creator-economy]]></category>
            <dc:creator><![CDATA[Wellstaq]]></dc:creator>
            <pubDate>Wed, 18 Nov 2026 21:01:24 GMT</pubDate>
            <atom:updated>2026-11-18T21:01:24.949Z</atom:updated>
            <content:encoded><![CDATA[<p>Why health creators with real trust still struggle to earn every month, and what a recurring offer looks like</p><figure><img alt="Your audience trusts you. Give them something to buy. Paid blood testing under your brand; Results in a portal with your name on it; Memberships and subscriptions that keep customers coming back. Learn more at Wellstaq.com." src="https://cdn-images-1.medium.com/max/1024/1*wGM_0_FwQtreEiCUTdGTqQ.png" /></figure><p>By Aaron Peden, Co-Founder &amp; CMO at Wellstaq. Disclosure: Wellstaq builds a platform for this, so I have a stake in the topic.</p><p>Plenty of health creators and coaches have an audience that genuinely trusts them. Far fewer have a business that earns every month.</p><p>The gap is usually the offer, not the audience.</p><h4>Free content, one-time products</h4><p>Most creator businesses run on content (free), a course or program (sold once), and maybe an affiliate link (someone else’s brand). When a follower asks “what should I do next?”, the answer often sends them somewhere else.</p><h4>What a next step under your brand looks like</h4><ul><li><strong>A paid first offer.</strong> A blood test the customer buys through your brand, collected through Quest Diagnostics or Labcorp, or at home where supported. A licensed clinician orders it.</li><li><strong>A place to come back to.</strong> Results delivered in a portal with your name on it.</li><li><strong>A reason to stay.</strong> Memberships and subscriptions built around customer goals, with access to independent clinicians when customers want to discuss results.</li></ul><p>Clinicians decide care. Your brand keeps the relationship.</p><h4>Questions to answer first</h4><ul><li>What can a new follower buy from you this week?</li><li>What do they buy after that?</li><li>Where does the relationship live: your brand, or someone else’s?</li></ul><p>Wellstaq connects the testing workflow, branded portal and memberships so a health brand can sell under its own name. Services and eligibility vary.</p><p><strong>Learn more at </strong><a href="https://wellstaq.com/"><strong>Wellstaq.com</strong></a><strong>.</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=86a87cd6a696" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Build Revenue That Recurs, Not a One-Time Sale]]></title>
            <link>https://medium.com/@wellstaq/build-revenue-that-recurs-not-a-one-time-sale-edb81da7d5e9?source=rss-9b39cb2d4f1e------2</link>
            <guid isPermaLink="false">https://medium.com/p/edb81da7d5e9</guid>
            <dc:creator><![CDATA[Wellstaq]]></dc:creator>
            <pubDate>Wed, 18 Nov 2026 17:00:24 GMT</pubDate>
            <atom:updated>2026-11-18T17:00:24.806Z</atom:updated>
            <content:encoded><![CDATA[<h4>A simple structure for health brands that want customers to come back</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*gT_lhv1Qu3YUnYr5S4F6zw.png" /></figure><p>By Aaron Peden, Co-Founder &amp; CMO at Wellstaq. Disclosure: Wellstaq builds a platform for this, so I have a stake in the topic.</p><p>A one-time sale is a transaction. A health brand needs a reason to keep serving the same customer.</p><h3>The structure</h3><ol><li><strong>Paid testing under your brand.</strong> A licensed clinician orders the test; the customer collects through Quest Diagnostics or Labcorp, or at home where supported.</li><li><strong>Results in your branded portal.</strong> The customer returns to you to see them.</li><li><strong>Relevant products and services after qualified review.</strong> Coaching, supplements or time with an independent clinician, where they fit. Results alone don’t determine product needs.</li><li><strong>Subscriptions, memberships and follow-up.</strong> The ongoing part is where recurring revenue comes from.</li></ol><h3>Why it works</h3><p>Each step creates a natural reason for the next conversation. The customer isn’t being pushed through a funnel; they’re getting continued service from a brand they already trust.</p><h3>Where to start</h3><p>Pick one buyer and one problem. Decide what the first paid step is, and what genuinely helpful follow-up looks like.</p><p>Wellstaq supports this flow under a brand’s own name. Services and eligibility vary.</p><p><strong>Learn more at </strong><a href="https://wellstaq.com/"><strong>Wellstaq.com</strong></a><strong>.</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=edb81da7d5e9" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Supplement Brands: Sell More Than the Bottle]]></title>
            <link>https://medium.com/@wellstaq/supplement-brands-sell-more-than-the-bottle-40e0570a36c0?source=rss-9b39cb2d4f1e------2</link>
            <guid isPermaLink="false">https://medium.com/p/40e0570a36c0</guid>
            <dc:creator><![CDATA[Wellstaq]]></dc:creator>
            <pubDate>Wed, 18 Nov 2026 00:00:35 GMT</pubDate>
            <atom:updated>2026-11-18T00:00:35.834Z</atom:updated>
            <content:encoded><![CDATA[<p><em>Why the customer relationship shouldn’t end at checkout</em></p><figure><img alt="Sell more than the bottle. Add paid blood testing under your brand; Clinician-guided care for eligible programs; Subscriptions and memberships around customer goals. Learn more at Wellstaq.com." src="https://cdn-images-1.medium.com/max/1024/1*DYE2XsUDTVvNU21hv1sTsA.png" /></figure><p>By Aaron Peden, Co-Founder &amp; CMO at Wellstaq. Disclosure: Wellstaq builds a platform for this, so I have a stake in the topic.</p><p>Supplement brands put most of their effort into the product and the first purchase. After that, the relationship is mostly reorder emails.</p><h3>The thin-relationship problem</h3><p>You know what someone bought. You rarely know why, whether it’s working for them, or what they need next. So the next message is a discount.</p><h3>Extending the journey</h3><p>A supplement brand can sell more of the customer’s health journey under its own name:</p><ul><li><strong>Paid blood testing,</strong> ordered by a licensed clinician, with collection through Quest Diagnostics or Labcorp and at-home options where supported</li><li><strong>Results in a branded portal</strong> the customer logs into</li><li><strong>Clinician-guided care</strong> for eligible programs, through independent clinicians</li><li><strong>Subscriptions and memberships</strong> built around the customer’s goals</li></ul><h3>The caveats that matter</h3><p>Results alone don’t determine product needs. Health data should be used only with consent and qualified review. Clinicians decide care and prescribing.</p><p>Supplements remain central. They just stop being the only reason the customer talks to you.</p><p><strong>Learn more at </strong><a href="https://wellstaq.com/"><strong>Wellstaq.com</strong></a><strong>.</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=40e0570a36c0" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Your Gym Members Already Ask About Bloodwork]]></title>
            <link>https://medium.com/@wellstaq/your-gym-members-already-ask-about-bloodwork-da70fb6b485e?source=rss-9b39cb2d4f1e------2</link>
            <guid isPermaLink="false">https://medium.com/p/da70fb6b485e</guid>
            <dc:creator><![CDATA[Wellstaq]]></dc:creator>
            <pubDate>Tue, 17 Nov 2026 21:01:19 GMT</pubDate>
            <atom:updated>2026-11-17T21:01:19.369Z</atom:updated>
            <content:encoded><![CDATA[<h4>How a gym can offer testing under its own brand while staying in its lane</h4><figure><img alt="Your members already ask about bloodwork. A testing offer with your gym’s name on it; Results in a portal your members log into; Coaching and supplements connected to their goals. Learn more at Wellstaq.com." src="https://cdn-images-1.medium.com/max/1024/1*Wnenl5KsfYAb7V8hJlXP4A.png" /></figure><p>By Aaron Peden, Co-Founder &amp; CMO at Wellstaq. Disclosure: Wellstaq builds a platform for this, so I have a stake in the topic.</p><p>Every gym owner has heard it: “Should I get my bloodwork done?” The safe answer is “ask your doctor.” It’s also the answer that sends the member, and the next purchase, somewhere else.</p><h3>A different answer</h3><p>A gym can offer blood testing as a service under its own name, without becoming a clinic, if the roles are clear.</p><ul><li><strong>A licensed clinician orders each test.</strong> The gym provides access and the experience.</li><li><strong>Collection happens at a real lab.</strong> Quest Diagnostics or Labcorp, with at-home options where supported.</li><li><strong>Results live in the member’s account,</strong> in a portal with the gym’s brand on it.</li><li><strong>Clinical questions go to clinicians.</strong> Members can discuss results with an independent clinician.</li></ul><h3>Where the gym adds value</h3><p>After that, the gym does what it does best: coaching and programming connected to the member’s goals, and supplements where they fit.</p><h3>Questions to answer before launch</h3><ul><li>Which tests can your members access where they live?</li><li>Who handles questions about results?</li><li>What do your coaches say, and not say, about results?</li></ul><p>Wellstaq supports this model for gyms and studios. Services and eligibility vary; clinicians decide care.</p><p><strong>Learn more at </strong><a href="https://wellstaq.com/"><strong>Wellstaq.com</strong></a><strong>.</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=da70fb6b485e" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[An Eligible GLP-1 Program, Step by Step, Under Your Brand]]></title>
            <link>https://medium.com/@wellstaq/an-eligible-glp-1-program-step-by-step-under-your-brand-63707cdb893c?source=rss-9b39cb2d4f1e------2</link>
            <guid isPermaLink="false">https://medium.com/p/63707cdb893c</guid>
            <category><![CDATA[telehealth]]></category>
            <category><![CDATA[wellness]]></category>
            <category><![CDATA[entrepreneurship]]></category>
            <category><![CDATA[business-health]]></category>
            <category><![CDATA[weight-loss]]></category>
            <dc:creator><![CDATA[Wellstaq]]></dc:creator>
            <pubDate>Tue, 17 Nov 2026 17:00:33 GMT</pubDate>
            <atom:updated>2026-11-17T17:00:33.177Z</atom:updated>
            <content:encoded><![CDATA[<p>An illustrative walkthrough of who does what, from the first test to ongoing care</p><p>By Aaron Peden, Co-Founder &amp; CMO at Wellstaq. Disclosure: Wellstaq builds a platform for this, so I have a stake in the topic.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*hYhEuzrbZuYWJ4URuEStyg.png" /></figure><p>GLP-1 weight-management programs get a lot of attention. For a wellness brand, the important question isn’t whether to be involved; it’s who does what.</p><h3>The split</h3><p>Your brand owns the customer experience: the storefront, intake, membership and follow-up. Independent clinicians own every clinical decision. A licensed pharmacy reviews and fills approved prescriptions.</p><h3>An illustrative journey</h3><ol><li><strong>Blood test and intake.</strong> The customer buys a test and completes intake through your brand. Testing is ordered when clinically appropriate.</li><li><strong>Clinician evaluation.</strong> An independent clinician reviews history, symptoms and results, async or by video where supported.</li><li><strong>Decision.</strong> If the clinician approves, a prescription is issued. If not, it isn’t.</li><li><strong>Pharmacy.</strong> A licensed pharmacy reviews and accepts the order.</li><li><strong>Membership.</strong> The customer continues with follow-up and ongoing care.</li></ol><h3>What to state plainly</h3><ul><li>No prescription is guaranteed.</li><li>Payment never determines prescribing or pharmacy decisions.</li><li>Program availability and clinical eligibility vary.</li></ul><p>Wellstaq supports eligible prescription programs under a brand’s own name, with licensed pharmacy fulfillment.</p><p><strong>Learn more at </strong><a href="https://wellstaq.com/"><strong>Wellstaq.com</strong></a><strong>.</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=63707cdb893c" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Results Make the Next Offer Relevant]]></title>
            <link>https://medium.com/@wellstaq/results-make-the-next-offer-relevant-0314349caa22?source=rss-9b39cb2d4f1e------2</link>
            <guid isPermaLink="false">https://medium.com/p/0314349caa22</guid>
            <dc:creator><![CDATA[Wellstaq]]></dc:creator>
            <pubDate>Tue, 17 Nov 2026 00:01:31 GMT</pubDate>
            <atom:updated>2026-11-17T00:01:31.150Z</atom:updated>
            <content:encoded><![CDATA[<p>How health brands can use lab results to guide what they offer, without overstepping</p><p>By Aaron Peden, Co-Founder &amp; CMO at Wellstaq. Disclosure: Wellstaq builds a platform for this, so I have a stake in the topic.</p><p>Most wellness brands choose their next offer the same way: what’s new, what has margin, what’s in stock. The customer is an afterthought.</p><p>Lab results offer a better starting point, if you respect the guardrails.</p><h4>Guardrail 1: consent</h4><p>A customer’s health data should only inform offers when they’ve agreed to it. Make that explicit, not buried.</p><h4>Guardrail 2: qualified review</h4><p>What a result means for a specific person is a clinical question. The right next step is often a conversation with an independent clinician, not a product page.</p><h4>Guardrail 3: results inform, they don’t decide</h4><p>A single value doesn’t establish that someone needs a supplement or a program. Treat results as context for a conversation.</p><h4>What a relevant next step looks like</h4><ul><li>Time with an independent clinician to discuss results</li><li>Coaching connected to the customer’s stated goal</li><li>Supplements, where they genuinely fit</li></ul><p>When those options live in the same place as the results, under your brand, the customer doesn’t have to piece the journey together.</p><p>That’s the flow Wellstaq supports: testing, results in a branded portal, and relevant products and services after qualified review.</p><p><a href="https://wellstaq.com/">Your health brand. Built for recurring revenue.</a></p><p>Learn more at Wellstaq.com.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=0314349caa22" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The Financial Upside of B2C Telehealth: What Hims & Hers, Ro and BetterHelp Built]]></title>
            <link>https://medium.com/@wellstaq/the-financial-upside-of-b2c-telehealth-what-hims-hers-ro-and-betterhelp-built-b1435c2928ab?source=rss-9b39cb2d4f1e------2</link>
            <guid isPermaLink="false">https://medium.com/p/b1435c2928ab</guid>
            <category><![CDATA[startup]]></category>
            <category><![CDATA[entrepreneurship]]></category>
            <category><![CDATA[business]]></category>
            <category><![CDATA[telehealth]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[Wellstaq]]></dc:creator>
            <pubDate>Thu, 12 Nov 2026 17:41:24 GMT</pubDate>
            <atom:updated>2026-11-13T01:02:09.674Z</atom:updated>
            <content:encoded><![CDATA[<p>Three public case studies, the playbook behind them, and what a health creator can launch under their own brand</p><p>Telehealth stopped being a pandemic stopgap a while ago. Some of the biggest direct-to-consumer health brands of the decade are telehealth companies, and their public numbers tell a clear story about where the money is, and about the one cost almost all of them carry.</p><p>If you are a coach, creator, gym owner or health expert with an audience, this matters for a simple reason: the most expensive part of their model is the part you may already have.</p><p>How big is the market?</p><p>Grand View Research projects the U.S. telehealth market could reach $150.13 billion by 2030, growing at a 23.8% compound annual rate from 2025 to 2030 (U.S. Telehealth Market report, October 2024). Treat that as what it is: a market-research estimate across a broad category that includes hardware, software and services. It is not a forecast for any single business.</p><p>The more useful evidence is what specific B2C companies have actually reported.</p><p>Case study 1: Hims &amp; Hers</p><p>The numbers. Hims &amp; Hers reported annual revenue of $872.0 million in 2023, $1,476.5 million in 2024 and $2,347.6 million in 2025 (Form 10-Q for the quarter ended September 30, 2026). In the third quarter of 2026 alone, revenue was $890.4 million, up 49% year over year, and the company had about 2.788 million subscribers (Q3 2026 results, November 9, 2026). Hims also lowered its 2026 adjusted EBITDA guidance in that same release, and gross margin fell to 57% from 74% a year earlier, so growth has not been free.</p><p>How it was built. In its own filings, Hims attributes subscriber growth to traffic driven by marketing, including ordinary-course campaigns and a Super Bowl campaign, plus an acquisition (Eucalyptus) and better onboarding. The business runs on subscriptions: customers agree to be billed on a recurring cadence for products and services. Its filings describe medication fulfillment through its own pharmacies and partner pharmacies.</p><p>The lesson. A consumer brand plus a recurring program, with clinicians and pharmacies behind it, can compound quickly. It also takes a lot of marketing.</p><p>Case study 2: Ro</p><p>The numbers. Ro is private, so there are no audited public financials. In a November 11, 2026 essay, Ro&#39;s founder and CEO, Zachariah Reitano, reports a $3B+ annualized run rate and nearly 10x growth since its 2022 rebuild. That is a company-reported run rate, not audited annual revenue.</p><p>How it was built. Ro was known mainly for sexual wellness treatments before it rebuilt its business around GLP-1 weight care, according to The New York Times as summarized by Quartz on November 11, 2026. It also reported not having raised new money from investors in years.</p><p>The lesson. The biggest swings in B2C telehealth came from choosing one high-demand program and building the whole experience around it.</p><p>Case study 3: BetterHelp</p><p>The numbers. BetterHelp, Teladoc Health’s online therapy business, generated $950.4 million of revenue in 2025, down 9% from $1,040.7 million in 2024. The segment spent $518.5 million on advertising and marketing in 2025, excluding stock-based compensation, and averaged 386,000 paying users (Teladoc Health 2025 Form 10-K and Q4 2025 results). Teladoc describes BetterHelp as predominantly marketed and sold direct-to-consumer.</p><p>How it was built. A subscription service with a recognizable consumer brand and heavy paid acquisition.</p><p>The lesson. More than half of the segment’s revenue went to advertising and marketing in 2025. At that scale, attention is bought every month.</p><figure><img alt="ellstaq diagram. Left, built over years by large B2C telehealth brands: a consumer brand, paid customer acquisition, subscriptions, a clinician network, pharmacy fulfillment. Right, with Wellstaq under your brand: your audience and brand, white-label blood lab testing, 503A telehealth, memberships, branded portal and intake. Footer: 503A is patient-specific compounding on a prescription; independent clinicians decide care; compounded drugs are not FDA-approved; no prescription is guaranteed." src="https://cdn-images-1.medium.com/max/1024/1*oGVAHHdcW2fwkrTBQaJINA.png" /><figcaption>What large B2C telehealth brands built over years, and what Wellstaq connects under your brand.</figcaption></figure><p>The playbook all three share</p><p>Strip away the brand names and the pattern is the same:</p><p>A brand people trust.</p><p>A recurring program people keep using.</p><p>Licensed clinicians making care decisions, and licensed pharmacies dispensing.</p><p>A steady, expensive stream of new customers.</p><p>That last item is where creators, coaches and health experts are different. You already have an audience that knows you. You do not have to buy attention the way a new consumer brand does. What you usually lack is the infrastructure: testing, clinical access, pharmacy connections, a member portal and recurring billing under your own name.</p><p>If that is where you are, <a href="https://attribution.wellstaq.com/go/wq_ca5aea0af7e44945">join the Wellstaq waitlist.</a> Founding enrollment opens December 7, 2026, to waitlist members only. No payment today; joining does not reserve a founding place.</p><p>Where Wellstaq fits</p><p>Wellstaq is white-label blood lab testing, 503A telehealth and memberships on one platform, under your brand. Your health brand. Built for recurring revenue.</p><p>White-label blood lab testing: testing and results delivered in your branded experience.</p><p>503A telehealth: access to independent licensed clinicians, with async and video visits where supported, and a 50-state physician network for clinician-directed prescribing when clinically appropriate.</p><p>Memberships: recurring programs inside your branded portal, with your own domain, intake and messaging.</p><p>What 503A means, in plain English. A 503A pharmacy compounds a medication for a specific patient based on a valid prescription. It is not a resale license or a loophole. Independent clinicians decide whether any treatment is appropriate, licensed pharmacies decide whether to dispense, compounded drugs are not FDA-approved, and a consultation never guarantees a prescription. Program, state and patient eligibility apply.</p><p>Why this is a strong way to start a white-label telehealth brand. The three companies above each assembled a brand, a clinical network, pharmacy relationships and a recurring program over years. Wellstaq connects labs, telehealth and memberships in one place so you can focus on the brand and the audience. Wellstaq states that it adds no markup and keeps no share of 503A prescription and doctor consultation rates; provider charges still apply.</p><p>Founder pricing. $497 per month platform pricing for one brand, price locked for life for the first 100 paid founding members, as published on wellstaq.com on November 12, 2026. Lab, care, pharmacy and other services are charged separately.</p><p>A 20-minute exercise before you build anything</p><ol><li>Write the one recurring program your audience already asks you about.</li><li>List who would own each step: your brand (audience, offer, coaching, support), the platform (portal, intake, testing workflow, messaging), independent clinicians (evaluation and prescribing decisions) and pharmacies (dispensing).</li><li>Write what a member would still value in month two.</li></ol><p>If those three answers come easily, the B2C telehealth model may fit your brand. Ready to see how it works under your own name? <a href="https://attribution.wellstaq.com/go/wq_ca5aea0af7e44945">Join the Wellstaq waitlist</a>. No payment today; joining does not reserve a founding place.</p><p>Sources (checked November 12, 2026)</p><p>Grand View Research, “U.S. Telehealth Market Size To Reach $150.13 Billion By 2030,” press release for the October 2024 report. <a href="https://www.grandviewresearch.com/press-release/us-telehealth-market-analysis">https://www.grandviewresearch.com/press-release/us-telehealth-market-analysis</a></p><p>Hims &amp; Hers Health, Inc., Form 10-Q for the quarter ended September 30, 2026 (SEC). <a href="https://www.sec.gov/Archives/edgar/data/1773751/000177375126000246/hims-20260930.htm">https://www.sec.gov/Archives/edgar/data/1773751/000177375126000246/hims-20260930.htm</a></p><p>Hims &amp; Hers Health, “Reports Third Quarter 2026 Financial Results,” November 9, 2026. <a href="https://investors.hims.com/news/news-details/2026/Hims--Hers-Health-Inc--Reports-Third-Quarter-2026-Financial-Results/default.aspx">https://investors.hims.com/news/news-details/2026/Hims--Hers-Health-Inc--Reports-Third-Quarter-2026-Financial-Results/default.aspx</a></p><p>Hims &amp; Hers Health, Q4 and full year 2025 shareholder letter, February 23, 2026 (SEC). <a href="https://www.sec.gov/Archives/edgar/data/1773751/000177375126000019/finalq42025shareholderle.htm">https://www.sec.gov/Archives/edgar/data/1773751/000177375126000019/finalq42025shareholderle.htm</a></p><p>Zachariah Reitano, “Refounding Ro to $3B+ Run Rate,” X essay, November 11, 2026. Exact wording: “In 2026, we’re at $3B+ run-rate” and “Since we refounded Ro, we’ve nearly 10’x the business.” <a href="https://x.com/ZReitano/status/2120502035455811893">https://x.com/ZReitano/status/2120502035455811893</a></p><p>Quartz, “Telehealth firm Ro is expected to report more than $3.2 billion in annualized revenue,” November 11, 2026, citing The New York Times — used only for Ro’s earlier sexual-wellness positioning, GLP-1 shift, and report that it had not raised new money in years; not used for the run-rate or growth multiple. https://qz.com/ro-telehealth-annualized-revenue-billion-glp-1–111126</p><p>Teladoc Health, Inc., 2025 Form 10-K (SEC). <a href="https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm">https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm</a></p><p>Teladoc Health, “Reports Fourth Quarter and Full Year 2025 Results.” <a href="https://ir.teladochealth.com/news-and-events/investor-news/press-release-details/2026/Teladoc-Health-Reports-Fourth-Quarter-and-Full-Year-2025-Results/default.aspx">https://ir.teladochealth.com/news-and-events/investor-news/press-release-details/2026/Teladoc-Health-Reports-Fourth-Quarter-and-Full-Year-2025-Results/default.aspx</a></p><p>Wellstaq homepage, pricing and trust pages, fetched November 12, 2026, 8:49 AM PT. https://wellstaq.com/</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b1435c2928ab" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[White-Label TRT Is Planned for 2027. Here’s What a Gym or Coaching Brand Would Actually Own]]></title>
            <link>https://medium.com/@wellstaq/white-label-trt-is-planned-for-2027-heres-what-a-gym-or-coaching-brand-would-actually-own-34bc92d2c845?source=rss-9b39cb2d4f1e------2</link>
            <guid isPermaLink="false">https://medium.com/p/34bc92d2c845</guid>
            <category><![CDATA[small-business]]></category>
            <category><![CDATA[health-technology]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[telehealth]]></category>
            <category><![CDATA[entrepreneurship]]></category>
            <dc:creator><![CDATA[Wellstaq]]></dc:creator>
            <pubDate>Thu, 12 Nov 2026 07:30:08 GMT</pubDate>
            <atom:updated>2026-11-12T07:30:08.293Z</atom:updated>
            <content:encoded><![CDATA[<p><em>Labs come first, clinicians decide, and your brand owns the experience. A planning guide for operators, with dated sources.</em></p><figure><img alt="Cover: White-label TRT is planned for 2027. Here’s what your brand would actually own. A planning guide for gyms, coaches and men’s health brands. Wellstaq TRT is planned for January 2027 and is not part of the current launch." src="https://cdn-images-1.medium.com/max/1024/1*FqPxjjJbazOpA46S2omgFw.png" /><figcaption>Illustrative cover, Wellstaq.</figcaption></figure><p><em>Disclosure: this article is published by Wellstaq, which builds branded platforms for health brands, so we have a commercial interest in this topic. It was drafted with AI assistance and edited by the Wellstaq team. It is general business education, not legal or medical advice.</em></p><p>If you run a gym, a coaching program or a men’s health community, TRT may already come up in your conversations. The usual answer is “talk to a doctor,” and the relationship you built leaves with that referral.</p><p>Wellstaq plans to add white-label TRT for health brands in January 2027, subject to clinical approval. It is not part of the current launch, and launch scope and timing are confirmed during onboarding. This guide is about the planning you can do before then: what your brand would own, what it never should, and the facts that shape every responsible program.</p><h3>1. Labs come first, not the prescription</h3><p>The most useful fact for an operator is also the least glamorous. FDA-approved testosterone labels tell prescribers to confirm the diagnosis of low testosterone with morning testosterone measured on at least two separate days, below the normal range, before starting treatment. We checked two current labels, both revised in July 2025, and both carry that instruction.</p><p>That changes how you should picture the product. A TRT program is not a checkout button. It is a sequence: testing, results, a clinical evaluation, and only then a decision. If your marketing skips straight to the prescription, it describes something that should not exist.</p><h3>2. Independent clinicians decide</h3><p>In a white-label model, the brand never decides who is treated. An independent licensed clinician reviews history, symptoms and lab results and decides whether TRT is appropriate, whether more testing is needed, or whether a different referral fits better.</p><p>Three lines belong in every plan, and in every piece of marketing:</p><ul><li>A consultation never guarantees a prescription.</li><li>Payment never determines prescribing or pharmacy decisions.</li><li>Eligibility depends on the program, state and patient.</li></ul><p>If you can’t say those three lines comfortably, you are not ready to put TRT under your brand.</p><p><strong>If you’d rather spend your time on the brand side of that line, Wellstaq’s free waitlist sends launch updates and shows the planned journey. No payment today; joining does not reserve a founding place: </strong><a href="https://wellstaq.com/"><strong>see the planned TRT journe</strong></a>y.</p><h3>3. Testosterone is a controlled substance, and the telemedicine rules are moving</h3><p>Testosterone is listed in Schedule III of the federal Controlled Substances Act (21 CFR 1308.13). That matters for any remote program, because prescribing a controlled substance by telemedicine follows DEA rules on top of state rules.</p><p>Here is where those rules stand as of November 11, 2026:</p><ul><li>Since 2020, temporary DEA and HHS flexibilities have let DEA-registered practitioners prescribe Schedule II through V medications by audio-video telemedicine without a prior in-person evaluation, if the other conditions are met. The fourth extension runs through December 31, 2026.</li><li>DEA proposed a permanent “special registration” for telemedicine in January 2025. A final rule has been under White House review since August 25, 2026. As of today, the Federal Register shows neither that final rule nor a further extension.</li></ul><p>We are not predicting what happens next. The practical lesson for a brand is simpler: never build a promise around “no visit needed.” Visit format is a clinical and legal question. Clinicians decide whether an in-person evaluation is needed, and your program should be ready for either answer.</p><h3>4. Product labeling is changing too</h3><p>FDA has updated testosterone labeling twice in under two years. In February 2025, it announced class-wide changes that added results from a large cardiovascular safety trial, removed boxed-warning language about increased cardiovascular risk, and added a blood pressure warning across testosterone products. In June 2026, FDA requested further updates, including removing a limitation of use for age-related low testosterone and revising prostate-related safety information. Some products still carry product-specific boxed warnings.</p><p>For an operator, the lesson isn’t to interpret those changes. It’s to keep clinical claims out of brand copy entirely. Labels, risks and suitability are for clinicians to discuss with patients. Your copy can describe the experience and who is responsible for each step.</p><h3>5. What your brand owns, and what it never should</h3><figure><img alt="Diagram, four roles in a white-label TRT program. Your brand: audience and offer, coaching, nonclinical support. Wellstaq: branded portal, intake and messaging, testing workflow. Independent clinicians: lab review, evaluation, prescribing decisions. Licensed pharmacies: dispensing only when prescribed and accepted. Illustrative; a consultation never guarantees a prescription." src="https://cdn-images-1.medium.com/max/1024/1*LKUmh0nHYJYnGKqCIqc7fQ.png" /><figcaption>Illustrative responsibility map.</figcaption></figure><p>Here is the responsibility map we use for planning:</p><ul><li><strong>Your brand:</strong> the audience, the offer, coaching, community and nonclinical support.</li><li><strong>Wellstaq:</strong> the branded portal, intake, testing workflow and messaging.</li><li><strong>Independent licensed clinicians:</strong> lab review, evaluation, prescribing decisions and follow-up.</li><li><strong>Licensed pharmacies:</strong> dispensing, only when a prescription is issued and accepted.</li></ul><p>Your brand never owns diagnosis, prescribing decisions, dosing or dispensing. The value you add is the part clinicians and pharmacies can’t: a community people already trust, coaching around the experience, and a clear place to come back to.</p><p>The diagram shows the same map. Your own agreement confirms the exact responsibilities.</p><h3>6. A 20-minute exercise for your team before January</h3><p>Sit down with whoever runs your member experience and answer three questions in writing:</p><ol><li><strong>Where do medical questions go?</strong> Name the route from your community to a clinician. A support inbox is not a care plan.</li><li><strong>How will you describe TRT without promising a result?</strong> Draft the sentence now. If it mentions speed, guarantees or how someone will feel, rewrite it.</li><li><strong>Which states do your members live in?</strong> Availability is confirmed per state and program, so know your map before you announce anything.</li></ol><p>If those answers come easily, you’re thinking like an operator rather than a reseller.</p><h3>How to talk about it before launch</h3><p>Say “planned” until it is live. Name who decides. Keep outcomes, timelines and prescription promises out of every post, email and page. That is how we are announcing our own plans, and it is the standard we’d suggest for any brand that wants men’s health to be part of its future.</p><p><strong>Want to see what the journey looks like from a first lab result to a clinician’s decision, under your own logo? </strong><a href="https://wellstaq.com/"><strong>See the planned TRT journey and join the free waitlist</strong></a><strong>.</strong> No payment today; joining does not reserve a founding place.</p><h3>Sources (checked November 11, 2026, PT)</h3><ul><li>Wellstaq homepage and program pages, fetched Nov 11, 2026, 2:38 PM PT: “TRT is coming January 2027 and is not included in the current launch offer.” and “Coming January 2027, subject to clinical approval.”</li><li>eCFR, 21 CFR 1308.13 (Schedule III), paragraph (f)(84), testosterone. ecfr.gov, read Nov 11, 2026.</li><li>DEA and HHS, Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, 90 FR 61301, published Dec 31, 2025, effective Jan 1 through Dec 31, 2026. federalregister.gov.</li><li>DEA, Special Registrations for Telemedicine and Limited State Telemedicine Registrations, proposed rule, 90 FR 6541, Jan 17, 2025; final rule received for OIRA review Aug 25, 2026 (RIN 1117-AB40). reginfo.gov, read Nov 11, 2026.</li><li>Federal Register search of DEA documents mentioning telemedicine, Sept 1 to Nov 11, 2026: no final special registration rule or fifth extension. federalregister.gov, read Nov 11, 2026, 2:39 PM PT.</li><li>FDA, “FDA issues class-wide labeling changes for testosterone products,” Feb 28, 2025. fda.gov.</li><li>FDA, “Testosterone Information,” content current as of June 23, 2026. fda.gov.</li><li>FDA-approved prescribing information for two testosterone products, revised July 2025 (accessdata.fda.gov), dosage and administration sections.</li></ul><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=34bc92d2c845" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Can your health brand offer doctor-prescribed GLP-1 care without practicing medicine?]]></title>
            <link>https://medium.com/@wellstaq/can-your-health-brand-offer-doctor-prescribed-glp-1-care-without-practicing-medicine-87e9b73946e1?source=rss-9b39cb2d4f1e------2</link>
            <guid isPermaLink="false">https://medium.com/p/87e9b73946e1</guid>
            <category><![CDATA[entrepreneurship]]></category>
            <category><![CDATA[startup]]></category>
            <category><![CDATA[telehealth]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[business-health]]></category>
            <dc:creator><![CDATA[Wellstaq]]></dc:creator>
            <pubDate>Wed, 11 Nov 2026 02:45:35 GMT</pubDate>
            <atom:updated>2026-11-11T02:45:35.865Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="GLP-1 care under your brand: start with who is responsible. Your brand, independent clinicians and an authorized pharmacy have distinct roles. General US business education; availability and eligibility apply." src="https://cdn-images-1.medium.com/max/1024/1*sRScv_u9fW9ojuZO-IzVNw.png" /><figcaption>GLP-1 care under your brand starts with who is responsible. Illustration by Wellstaq.</figcaption></figure><h4>Start with the people responsible for each step of the member journey.</h4><p>Disclosure: this article is published by Wellstaq, which builds branded platforms for health brands, so we have a commercial interest in this topic.</p><p>Saying yes to GLP-1 care is easy on a landing page. Deciding who answers a member’s treatment question three weeks later is not, and that is where a health brand can end up in a role it isn’t allowed to play.</p><p>A gym owner already has a community. A coach already has an audience. A wellness founder may already know how to build a service people want to use. The question is whether prescription GLP-1 care can become part of that brand’s customer experience, and who would be responsible for what.</p><p>The first useful step is to draw the operating model. A prescription is a clinical decision for a patient. It does not, by itself, give a business blanket permission to resell medication or practice medicine.</p><p>For an operator, the real question is: <strong>what would need to be true for this particular service, in these particular states, under these particular agreements?</strong></p><h3>Put an owner beside each part of the journey</h3><p>Take an illustrative coaching brand. A member discovers its service, learns what is available and asks whether prescription care might be appropriate.</p><p>The brand can explain how its service works. A qualified clinician must make the medical decisions. A pharmacy must be authorized to carry out the relevant dispensing activity. The member needs to know where to return when the next question requires medical judgment.</p><p>Use this planning map:</p><p><strong>“What is this service, and how do I navigate it?”</strong></p><p>Brand support and the agreed member experience.</p><p><strong>“Is treatment appropriate for me?”</strong></p><p>Independent clinical evaluation and decision-making.</p><p><strong>“How is a prescribed medicine dispensed?”</strong></p><p>The authorized pharmacy and the applicable dispensing process.</p><p><strong>“I have a question about my treatment.”</strong></p><p>A clear route to the clinical team and appropriate follow-up.</p><p><strong>“What connects those steps?”</strong></p><p>The agreed platform and operational workflows.</p><p>This is a planning example, not a customer case study or proof that the arrangement is lawful. It exposes the questions that need answers before an offer reaches members.</p><figure><img alt="One experience. Clear roles. Put a responsible team beside every step. Independent clinicians decide care. Pharmacy authorization and patient eligibility apply. Roles: brand, member experience and nonclinical support; clinicians, evaluation and care decisions; pharmacy, authorized dispensing; counsel, business model review." src="https://cdn-images-1.medium.com/max/1024/1*j5nVd_Is3Hp8JKNPSehp5w.png" /><figcaption>Illustrative responsibility map: brand, independent clinicians, authorized pharmacy and your counsel each own a distinct part.</figcaption></figure><h3>Your map must work in the intended states</h3><p>Telehealth does not remove geography from medical practice. HHS describes several state-dependent routes for clinicians to practice across state lines, including licensing, registration and other permitted pathways. The patient’s location matters. HHS licensure guidance.</p><p>Business ownership and control also need attention. California’s medical board, for example, explains restrictions on non-physicians controlling clinical decisions. That is a state example, not a universal ownership template. Have qualified healthcare counsel review your actual structure, agreements and jurisdictions. Medical Board of California.</p><h3>Be precise about the medication pathway</h3><p>FDA-approved medicines and compounded preparations are different regulatory categories. FDA states that compounded drugs are not FDA-approved. Its current GLP-1 guidance also warns against presenting compounded products as the same as approved drugs. FDA’s GLP-1 guidance.</p><p>Do not build a launch plan around an assumed shortage exception or treat a formula change as automatic permission. Compounding rules involve specific conditions, including distinctions between 503A and 503B pathways. A clinician, pharmacy and legal team need to evaluate the actual proposal against current requirements. FDA compounding clarification.</p><p>Your marketing should be equally precise. Avoid promises that everyone qualifies, that a consultation guarantees a prescription, or that a particular result is assured. The FTC evaluates both explicit claims and the messages consumers reasonably take from an advertisement. FTC health-products guidance.</p><h3>Where Wellstaq fits</h3><p>Wellstaq helps connect a branded member experience with supported intake, messaging and service workflows. Its role is to help organize the experience around agreed independent care and pharmacy connections. Program availability, locations and launch scope are confirmed before launch; independent clinicians decide care. <a href="https://wellstaq.com/">See how Wellstaq works</a>.</p><p>For a founder, the useful shift is from “What can I put on a landing page?” to “Can my member understand and navigate every step?”</p><p>That includes what happens after the first interaction. Continuing access, clear support and a coherent service can be part of ongoing member value. They should reflect an actual need and a deliverable experience. Neither clinical outcomes nor business results are guaranteed.</p><h3>A practical prelaunch exercise</h3><p>Complete these three sentences with your prospective platform and professional advisers:</p><ol><li>“Our brand is responsible for ___, and the clinical team is responsible for ___.”</li><li>“When a member has a medical question, they contact ___ through ___.”</li><li>“Before we offer this in ___, we will confirm ___.”</li></ol><p>If an answer is vague, make it specific before launch. This exercise starts the discussion; it does not replace a full review of applicable requirements, including privacy and referral arrangements.</p><p>Which of those three sentences would your team struggle to finish today? If you want to see what a branded member journey looks like when every handoff has an owner, <a href="https://wellstaq.com/">see how it works and join Wellstaq’s free waitlist</a> for launch updates and a founding-enrollment invitation.</p><p>No payment today; joining does not reserve a founding place.</p><p><em>General US business education, checked November 10, 2026. Requirements depend on the actual arrangement and jurisdiction. This article is not individualized legal or medical advice.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=87e9b73946e1" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>